Contribution of radionuclide imaging to radiation oncology

Journal Article · Tue Jan 01 04:00:00 EST 1985 · Semin. Nucl. Med.; (United States)

DOI:https://doi.org/10.1016/S0001-2998(85)80042-8· OSTI ID:5553041

Mansfield, C M; Park, C H

Radionuclide imaging has been helpful to oncologists in the initial evaluation and follow-up of patients with primary and metastatic disease. With the introduction of ultrasound and computed tomography, there has been some reduction in the number of radionuclide imaging procedures. These imaging modalities should be used to complement one another. With the introduction of single-photon emission computed tomography in clinical nuclear medicine, there will be a significant improvement in the sensitivity, accuracy, and quantitative ability to detect abnormal lesions. There are intensive efforts in the development of tumor imaging using new agents. Specific antibodies for surface tumor antigens can be labeled with radioisotopes and used as tools for screening primary tumors and metastatic lesions. Therefore, for the present, radionuclide imaging will continue to contribute to clinical oncology. 59 references.

• Research Organization: Thomas Jefferson Univ. Hospital, Philadelphia, PA
• OSTI ID: 5553041
• Journal Information: Semin. Nucl. Med.; (United States), Journal Name: Semin. Nucl. Med.; (United States) Vol. 15:1; ISSN SMNMA
• Country of Publication: United States
• Language: English

Related Subjects

550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
COMPUTERIZED TOMOGRAPHY
COUNTING TECHNIQUES
DIAGNOSTIC TECHNIQUES
DIAGNOSTIC USES
DISEASES
EMISSION COMPUTED TOMOGRAPHY
IMAGES
MEDICINE
METASTASES
NEOPLASMS
NUCLEAR MEDICINE
RADIOISOTOPE SCANNING
TOMOGRAPHY
USES